Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Peter Taillac, MD, FAEMS
Original Contribution
EMS State of the Sciences Conference: Treatment Options for Hypoglycemia: Should It Be Gluca-gone?
07/01/2015
Peter Taillac , MD, FAEMS;
Is stocking glugacon worth it?
Is stocking glugacon worth it?
Is stocking glugacon worth it?
07/01/2015
EMSWorld
Original Contribution
Resident Eagle: Naloxone Guidance for EMS
01/01/2020
Peter Taillac , MD, FAEMS;
A team of experts defines optimal out-of-hospital treatment.
A team of experts defines optimal out-of-hospital treatment.
A team of experts defines...
01/01/2020
EMSWorld
Original Contribution
Ojo de Águila: Guías sobre Naloxona para el SEM
04/22/2020
Peter Taillac , MD, FAEMS;
Todos los proveedores del SEM son muy conscientes de la crisis de los opioides hoy en día.
Todos los proveedores del SEM son muy conscientes de la crisis de los opioides hoy en día.
Todos los proveedores del SEM...
04/22/2020
EMS World Américas
Resident Eagle: Naloxone Guidance for EMS
01/01/2020
Peter Taillac , MD, FAEMS;
A team of experts defines optimal out-of-hospital treatment.
A team of experts defines optimal out-of-hospital treatment.
A team of experts defines...
01/01/2020
EMSWorld
Featured CME Course
Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes
Upcoming Events
February 7 – February 9
February 27 – March 1
March 17 – March 19
March 22 – March 23
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 4
May 1 – May 3
May 19 – May 21
See Full Calendar